Zobrazeno 41 - 50
of 92
pro vyhledávání: '"Willenbacher W"'
Autor:
Willenbacher E; Internal Medicine V. Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria., Willenbacher W; Internal Medicine V. Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.; Oncotyrol, Centre for Personalized Cancer Medicine, Innsbruck, Austria., Wolf DG; Internal Medicine V. Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.; Medical Clinic 3, Oncology, Haematology, Rheumatology and Immunoncology, University Clinic Bonn (UKB), Bonn, Germany., Zelger B; Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Peschel I; Institute for Medical and Chemical Laboratory Diagnostics, Medical University Innsbruck, Innsbruck, Austria., Manzl C; Division of General Pathology, Department of Pathology, Innsbruck Medical University, Innsbruck, Austria., Haun M; Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Brunner A; Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Jul; Vol. 186 (1), pp. 189-191. Date of Electronic Publication: 2019 Feb 14.
Autor:
Willenbacher E; Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Willenbacher W; Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.; Oncotyrol, Center for Personalized Cancer Medicine, Innsbruck, Austria., Loeffler-Ragg J; Internal Medicine II, Pneumology, Innsbruck Medical University, Innsbruck, Austria.
Publikováno v:
Thorax [Thorax] 2019 Jun; Vol. 74 (6), pp. 620-622. Date of Electronic Publication: 2019 Jan 19.
Autor:
Bohn JP; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria., Willenbacher W; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.; b Oncotyrol, Center for Personalized Cancer Medicine , Innsbruck , Austria., Haas G; c Department of Ophthalmology and Optometry , Medical University of Innsbruck , Innsbruck , Austria., Peschel I; d Central Institute for Medical and Chemical Laboratory Diagnostics , Medical University of Innsbruck , Innsbruck , Austria., Oberacher H; e Institute of Legal Medicine and Core Facility Metabolomics , Medical University of Innsbruck , Innsbruck , Austria., Steurer M; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Jun; Vol. 60 (6), pp. 1584-1586. Date of Electronic Publication: 2019 Jan 11.
Autor:
Willenbacher E; Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck 6020, Austria. ella.willenbacher@i-med.ac.at., Khan SZ; Department of Clinical Oncology, BINOR Cancer Hospital, Bannu 28100, Pakistan. skhanizhere0@gmail.com., Mujica SCA; Department of Molecular Biology, Laboratorio Blau, Caracas 1071, Venezuela. altunamujica.md@gmail.com., Trapani D; Department of Oncology and Hematology, University of Milan, European Institute of Oncology, 20122 Milan, Italy. dario.trapani@ieo.it., Hussain S; Medical Oncology Department, KAMC NGHA, Riyadh 14413, Saudi Arabia. oncologysh@gmail.com., Wolf D; Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck 6020, Austria. dominik.wolf@i-med.ac.at., Willenbacher W; Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck 6020, Austria. wolfgang.willenbacher@tirol-kliniken.at.; Oncotyrol, Center for Personalized Cancer Therapy, Innsbruck 6020, Austria. wolfgang.willenbacher@tirol-kliniken.at., Spizzo G; Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck 6020, Austria. gilbert.spizzo@i-med.ac.at.; Oncologic Day Hospital, 39042 Bressanone, Italy. gilbert.spizzo@i-med.ac.at., Seeber A; Department of Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck 6020, Austria. andreas.seeber@tirol-kliniken.at.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2019 Apr 12; Vol. 20 (8). Date of Electronic Publication: 2019 Apr 12.
Autor:
Bohn JP; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria., Willenbacher W; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.; b Oncotyrol , Center for Personalized Cancer Medicine , Innsbruck , Austria., Peschel I; c Central Institute for Medical and Chemical Laboratory Diagnostics , Medical University Innsbruck , Innsbruck , Austria., Oberacher H; d Institute of Legal Medicine and Core Facility Metabolomics , Medical University of Innsbruck , Innsbruck , Austria., Steurer M; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Feb; Vol. 60 (2), pp. 550-552. Date of Electronic Publication: 2018 Jul 22.
Autor:
Mohty M; Hematology and Cellular Therapy Department, Saint-Antoine Hospital, Pierre & Marie Curie University, Paris, France. Electronic address: mohamad.mohty@inserm.fr., Terpos E; Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece., Mateos MV; Servicio de Hematologia, Hospital Universitario de Salamanca, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Cellular del Cáncer (Universitario de Salamanca-Consejo Superior de Investigaciones Científicas), Salamanca, Spain., Cavo M; Seràgnoli Institute of Hematology, University of Bologna, Bologna, Italy., Lejniece S; Department of Doctoral Studies, Riga Stradiņš University, Riga, Latvia., Beksac M; Department of Hematology, Ankara University, Ankara, Turkey., Bekadja MA; Hematology and Cell Therapy, Etablissement Hospitalier Universitaire, Oran, Algeria., Legiec W; Department Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland., Dimopoulos M; Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece., Stankovic S; University Clinic of Hematology, Medical Faculty, Skopje, Macedonia., Durán MS; Hematologia, Complejo Hospitalario de Jaén, Jaén, Spain., De Stefano V; Institute of Hematology, Catholic University, Rome, Italy., Corso A; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy., Kochkareva Y; State Budget Healthcare Institution of Moscow, City Outpatient Clinic, 68 of Healthcare Department of Moscow, Branch 3, Moscow, Russia., Laane E; North Estonia Medical Centre Foundation, Tallinn, Estonia., Berthou C; Université de Bretagne Occidentale, Brest, France., Salwender H; Multiples Myelom, Asklepios Klinik Altona, Hamburg, Germany., Masliak Z; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., Pečeliūnas V; Hematology, Oncology, and Transfusion Medicine Center, Vilnius University Hospital, Santariskiu Klinikos, Vilnius, Lithuania., Willenbacher W; Universitätsklinik Innsbruck Innere Medizin V, and Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria., Silva J; Department of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada., Louw V; Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa., Nemet D; Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia., Borbényi Z; Szegedi Tudomanyegyetem, II. Belgyógyászati Klinika, Szeged, Hungary., Abadi U; Hematology, Meir Medical Center, Kfar Saba, Israel., Pedersen RS; Regionshospitalet i Holstebro, Medicinsk Afdeling, Holstebro, Denmark., Černelč P; Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia., Potamianou A; Janssen-Cilag, Neuss, Germany., Couturier C; Janssen-Cilag, Issy-les-Moulineaux, France., Feys C; Janssen Research and Development, Beerse, Belgium., Thoret-Bauchet F; Janssen-Cilag, Issy-les-Moulineaux, France., Boccadoro M; Myeloma Unit, Division of Hematology, Città della Salute e della Scienza, University of Torino, Turin, Italy.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2018 Oct; Vol. 18 (10), pp. e401-e419. Date of Electronic Publication: 2018 Jun 25.
Autor:
Willenbacher W; Department of Hematology and Oncology, Innsbruck Medical University, 6020 Innsbruck, Austria. Wolfgang.Willenbacher@oncotyrol.at.; Oncotyrol, Center for Personalized Cancer Medicine, 6020 Innsbruck, Austria. Wolfgang.Willenbacher@oncotyrol.at., Seeber A; Department of Hematology and Oncology, Innsbruck Medical University, 6020 Innsbruck, Austria. andreas.seeber@tirol-kliniken.at., Steiner N; Department of Hematology and Oncology, Innsbruck Medical University, 6020 Innsbruck, Austria. Normann.Steiner@i-med.ac.at., Willenbacher E; Department of Hematology and Oncology, Innsbruck Medical University, 6020 Innsbruck, Austria. ella.willenbacher@i-med.ac.at., Gatalica Z; Caris Life Sciences, Phoenix, AZ 85040, USA. zgatalica@carisls.com., Swensen J; Caris Life Sciences, Phoenix, AZ 85040, USA. jswensen@carisls.com., Kimbrough J; Caris Life Sciences, Phoenix, AZ 85040, USA. jkimbrough@carisls.com., Vranic S; College of Medicine, Qatar University, Doha 2713, Qatar. svranic@qu.edu.qa.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2018 Jul 18; Vol. 19 (7). Date of Electronic Publication: 2018 Jul 18.
Autor:
Buske C; Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de., Sadullah S; James Paget University Hospital, Norfolk, UK., Kastritis E; National and Kapodistrian University of Athens, Athens, Greece., Tedeschi A; Department of Haematology, Aziende Socio Sanitarie Territoriali Grande Ospedale Metropolitano Niguarda, Milan, Italy., García-Sanz R; Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Bolkun L; Medical University Hospital of Bialystok, Bialystok, Poland., Leleu X; Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, Hôpital de La Milétrie, Centre Hospitalier Universitaire, Poitiers, France., Willenbacher W; Innsbruck Medical University, Innsbruck, Austria; Oncotyrol-Center for Personalized Cancer Medicine, Innsbruck, Austria., Hájek R; Department of Hemato-oncology, University Hospital of Ostrava and Faculty of Medicine Ostrava, University of Ostrava, Ostrava, Czech Republic., Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands., Cheng M; Pharmacyclics LLC, Sunnyvale, CA, USA., Bilotti E; Pharmacyclics LLC, Sunnyvale, CA, USA., Graef T; Pharmacyclics LLC, Sunnyvale, CA, USA., Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2018 Jul; Vol. 5 (7), pp. e299-e309.
Autor:
Raje N; a Massachusetts General Hospital Cancer Center , Boston , MA , USA., Roodman GD; b Indiana University Simon Cancer Center , Indianapolis , IN , USA., Willenbacher W; c Innsbruck University Hospital Internal Medicine V: Hematology & Oncology & OncoTyrol - Center of Personalized Cancer Medicine , Innsbruck , Austria., Shimizu K; d Department of Hematology/Oncology , National Hospital Organization Higashi Nagoya National Hospital , Nagoya , Japan., García-Sanz R; e Hospital Universitario de Salamanca , Salamanca , Spain., Terpos E; f University of Athens School of Medicine, Alexandra General Hospital , Athens , Greece., Kennedy L; g Epiphany , Los Angeles , CA , USA., Sabatelli L; h Amgen (Europe) GmbH , Zug , Switzerland., Intorcia M; h Amgen (Europe) GmbH , Zug , Switzerland., Hechmati G; i Global Health Economics, Amgen Inc , Thousand Oaks , CA , USA.
Publikováno v:
Journal of medical economics [J Med Econ] 2018 May; Vol. 21 (5), pp. 525-536. Date of Electronic Publication: 2018 Mar 05.
Autor:
Mondello P; Department of Human Pathology, University of Messina, Messina, Italy patriziamondello@hotmail.it.; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy.; Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, Cornell University, New York, USA., Steiner N; Internal Medicine V: Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria., Willenbacher W; Internal Medicine V: Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria., Cerchione C; Haematology Division, 'Federico II' University Hospital, Naples, Italy., Nappi D; Haematology Division, 'Federico II' University Hospital, Naples, Italy., Mauro E; Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy., Ferrero S; Department of Molecular Biotechnologies and Health Sciences, Division of Hematology AOU 'Città della Salute e della Scienza di Torino,', Turin, Italy., Cuzzocrea S; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy., Mian M; Haematology Division, 'Federico II' University Hospital, Naples, Italy.; Department of Hematology & CBMT, Ospedale di Bolzano, Bolzano, Italy.
Publikováno v:
The oncologist [Oncologist] 2018 Apr; Vol. 23 (4), pp. 454-460. Date of Electronic Publication: 2018 Jan 09.